Faster, Better Bioprocessing in 2020: Achieving effective manufacturing processes and sufficient capacity remains a top priority across a diversified biologic drug pipeline.

Detalles Bibliográficos
Publicado en:BioPharm International Vol. 33; no. 1; pp. 10 - 13
Autor principal: PETERS, RITA
Formato: Journal Article
Publicado: MJH Life Sciences Jan2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141508293&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 141508293
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Jan2020
      vid: 33
      iid: 1
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        141508293
        141508293
      ppf: 10
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Faster, Better Bioprocessing in 2020: Achieving effective manufacturing processes and sufficient capacity remains a top priority across a diversified biologic drug pipeline.
      aug:
        au: PETERS, RITA
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N